Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $25.90, with a market capitalization of 147.62B. The stock trades at a price-to-earnings (P/E) ratio of 19.86 and offers a dividend yield of 6.6%.
On 2026-05-23, Pfizer(PFE) stock traded between a low of $25.76 and a high of $26.15. Shares are currently priced at $25.90, which is +0.5% above the low and -1.0% below the high.
The Pfizer(PFE)'s current trading volume is 22.32M, compared to an average daily volume of 32.42M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $22.88.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $22.88.
PFE News
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Meet Samuel – Your Personal Investing Prophet Start...
Key Points Investors tend to jump from one hot investment idea to another. Right now, GLP-1 drugs are the hot story, and this pharmaceutical giant isn't even...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Sam...
Analyst ratings
54%
of 28 ratingsMore PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Sam...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Sam...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Sam...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Sam...
Goldman Sachs analyst Asad Haider maintained a Hold rating on Pfizer yesterday and set a price target of $26.00. Meet Samuel – Your Personal Investing Prophet S...
BMO Capital analyst Evan Seigerman maintained a Buy rating on Pfizer yesterday and set a price target of $34.00. Meet Samuel – Your Personal Investing Prophet S...
Earlier in May 2026, Pfizer reported strong Phase 2 data for its investigational 25‑valent pneumococcal conjugate vaccine in infants and secured a European Comm...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.